INS and metabolic syndrome: In addition, Berberine exerts hepatoprotective effects by inhibiting lipogenesis and gluconeogenesis while improving insulin sensitivity and lipid profiles (Koperska et al., 2022).Ginsenoside Rb1 demonstrates significant improvements in dyslipidemia (Kim et al., 2019).